N Wang, H Zhang, Y Zhou, H Jiang, B Dai, M Sun… - BMC infectious …, 2019 - Springer
Background In settings such as China, where universal implementation of directly observed
therapy (DOT) is not feasible, innovative approaches are needed to support patient …